第 1 到 300 筆結果,共 300 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function | Li Y.-T.; CHUN-JEN LIU ; JIA-HORNG KAO ; Lin L.-F.; Tu H.-C.; Wang C.-C.; Huang P.-H.; Cheng H.-R.; PEI-JER CHEN ; DING-SHINN CHEN ; Wu H.-L. | Hepatology | 1 | 1 | |
2 | 2020 | Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy | TAI-CHUNG TSENG ; Peng C.-Y; Hsu Y.-C; TUNG-HUNG SU ; Wang C.-C; CHUN-JEN LIU ; HUNG-CHIH YANG ; Yang W.-T; Lin C.-H; Yu M.-L; Lai H.-C; Tanaka Y; Nguyen M.H; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver Cancer | 17 | 13 | |
3 | 2020 | Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan | CHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 4 | 4 | |
4 | 2020 | Hepatitis C virus genotypes 1–3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes | Hsu C.-S.; Liu W.-L.; Li Q.; Lowey B.; Hertz L.; Chao Y.-C.; Liang T.J.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 1 | 0 | |
5 | 2020 | Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Yang S.-S.; Peng C.-Y.; Lin W.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 20 | 20 | |
6 | 2020 | Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer | TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | International Journal of Cancer | 4 | 4 | |
7 | 2020 | Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; CHIEN-CHING HUNG ; SZU-MIN HSIEH ; TUNG-HUNG SU ; HSIN-YUN SUN ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 21 | 20 | |
8 | 2020 | Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing | Yang Y.-C.; Chen Y.-H; JIA-HORNG KAO ; Ching C; Liu I.-J; Wang C.-C; Tsai C.-H; Wu F.-Y; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; HUNG-CHIH YANG | Molecular Therapy - Nucleic Acids | 59 | 52 | |
9 | 2020 | Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals | CHEN-HUA LIU ; Lee M.-H.; JOU-WEI LIN ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 43 | |
10 | 2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 8 | 6 | |
11 | 2020 | Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis | TUNG-HUNG SU ; Peng C.-Y; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 10 | 8 | |
12 | 2020 | HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chang C.T; TUNG-HUNG SU ; Yang W.-T; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 32 | |
13 | 2020 | High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy | Chang W.-Y.; Chiu Y.-C; Chiu F.-W; Hsu Y.-C; TAI-CHUNG TSENG ; Cheng P.-N; Yang S.-S; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 5 | 5 | |
14 | 2019 | Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma | SIH-HAN LIAO ; TUNG-HUNG SU ; YUNG-MING JENG ; PO-CHIN LIANG ; DING-SHINN CHEN ; CHIEN-HUNG CHEN ; JIA-HORNG KAO | Hepatology | 48 | 51 | |
15 | 2019 | Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis | CHEN-HUA LIU ; Shih Y.-L; Yang S.-S; Lin C.-L; YU-JEN FANG ; Cheng P.-N; Chen C.-Y; Peng C.-Y; Hsieh T.-Y; Chiu Y.-C; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
16 | 2019 | Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C | SHIH-JER HSU ; Chiu M.-C.; YU-JEN FANG ; Yang T.-H.; Yu J.-J.; CHIEH-CHANG CHEN ; Kuo C.-C.; Lee J.-Y.; CHIEN-HUNG CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 19 | 16 | |
17 | 2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
18 | 2019 | Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma | Li Y.-T.; Wu H.-L.; JIA-HORNG KAO ; Cheng H.-R.; MING-CHIH HO ; Wang C.-C.; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology | 7 | 7 | |
19 | 2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 29 | 26 | |
20 | 2019 | Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection | CHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; CHUN-MING HONG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 14 | 15 | |
21 | 2019 | Profile and value of FIB-4 in patients with dual chronic hepatitis C and B | CHUN-JEN LIU ; TAI-CHUNG TSENG ; Yang W.-T; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 10 | 9 | |
22 | 2019 | High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Huang Y.-T; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 94 | 76 | |
23 | 2019 | NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging | TUNG-HUNG SU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; Adhoute X; Bourlière M; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 3 | 3 | |
24 | 2019 | Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions | Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; SHIH-JER HSU ; CHEN-HUA LIU ; Huang C.-F.; Su C.-W.; Huang J.-F.; CHUN-JEN LIU ; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 8 | |
25 | 2018 | Preface | JIA-HORNG KAO ; DING-SHINN CHEN | Hepatitis B Virus and Liver Disease | 0 | 0 | |
26 | 2018 | Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection | CHEN-HUA LIU ; HSIN-YUN SUN ; CHUN-JEN LIU ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; Lo Y.-C; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 25 | 21 | |
27 | 2018 | Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy | TUNG-HUNG SU ; Liao C.-H; CHEN-HUA LIU ; KAI-WEN HUANG ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Radiology | 17 | 14 | |
28 | 2018 | Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 19 | 18 | |
29 | 2018 | Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection | CHEN-HUA LIU ; YIH-SHARNG CHEN ; SHOEI-SHEN WANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 26 | 21 | |
30 | 2018 | Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 57 | 52 | |
31 | 2018 | Hepatitis B virus and liver disease | JIA-HORNG KAO ; DING-SHINN CHEN | Hepatitis B Virus and Liver Disease | 0 | 0 | |
32 | 2018 | A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients | CHEN-HUA LIU ; CHUN-JEN LIU ; CHUN-MING HONG ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Chen K.-M; Huang Y.-P; Yeh Y.-M; Tien H.-L; Liu Y.-C; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Gastroenterology and Hepatology (Australia) | 15 | 15 | |
33 | 2018 | Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | PLoS ONE | 11 | 10 | |
34 | 2018 | Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 25 | 24 | |
35 | 2018 | Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study | CHEN-HUA LIU ; Huang Y.-J; Yang S.-S; Chang C.-H; Yang S.-S; HSIN-YUN SUN ; CHUN-JEN LIU ; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 25 | 23 | |
36 | 2017 | De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline | Lin Y.-Y.; Hsieh C.-H.; J. H. Chen ; X. M. Lu; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; HURNG-YI WANG | BMC Bioinformatics | 13 | 11 | |
37 | 2017 | Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis | TUNG-HUNG SU ; Shiau C.-W; Jao P; Yang N.-J; Tai W.-T; CHUN-JEN LIU ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHEN-HUA LIU ; KAI-WEN HUANG ; Hu T.-C; Huang Y.-J; YAO-MING WU ; Chen L.-J; PEI-JER CHEN ; DING-SHINN CHEN ; Chen K.-F; JIA-HORNG KAO | Scientific Reports | 12 | 11 | |
38 | 2017 | Strategies to manage hepatitis C virus infection disease burden-Volume 4 | DING-SHINN CHEN ; Hamoudi W.; Mustapha B.; Layden J.; Nersesov A.; Reic T.; Garcia V.; Rios C.; Mateva L.; Njoya O.; Al-Busafi S.A.; Abdelmageed M.K.; Abdulla M.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; PEI-JER CHEN ; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; JIA-HORNG KAO ; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Lukšić B.; Maaroufi A.; Malu A.O.; Mitova R.; Mohamed R.; Morović M.; Murphy K.; Nde H.; Ngige E.; Njouom R.; Nonković D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Rinke de Wit T.; Robbins S.; Roberts L.R.; Sanad S.J.; Sharma M.; Simonova M.; TUNG-HUNG SU ; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Schmelzer J.D. | Journal of Viral Hepatitis | 17 | 14 | |
39 | 2017 | Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; YU-JEN FANG ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Open Forum Infectious Diseases | 42 | 39 | |
40 | 2017 | Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 42 | 39 | |
41 | 2017 | Historical epidemiology of hepatitis C virus in select countries-volume 4 | Maaroufi A.; Vince A.; Himatt S.M.; Mohamed R.; Fung J.; Opare-Sem O.; Workneh A.; Njouom R.; Al ghazzawi I.; Abdulla M.; Kaliaskarova K.S.; Owusu-Ofori S.; Abdelmageed M.K.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; DING-SHINN CHEN ; PEI-JER CHEN ; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kamel Y.; JIA-HORNG KAO ; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Lukšić B.; Malu A.O.; Mateva L.; Mitova R.; Morović M.; Murphy K.; Mustapha B.; Nde H.; Nersesov A.; Ngige E.; Njoya O.; Nonković D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Simonova M.; TUNG-HUNG SU ; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Wani H.U.; Wong V.W.S.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Razavi-Shearer K. | Journal of Viral Hepatitis | 28 | 26 | |
42 | 2017 | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4 | Chan H.L.Y.; Chen C.J.; Omede O.; Al Qamish J.; Al Naamani K.; Bane A.; Tan S.S.; Simonova M.; Cardenas I.; Derbala M.; Akin O.; Phillips R.O.; Abdelmageed M.K.; Abdulla M.; Adda D.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; DING-SHINN CHEN ; PEI-JER CHEN ; Chien R.N.; Chuang W.L.; Cuellar D.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; JIA-HORNG KAO ; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Lukšić B.; Maaroufi A.; Malu A.O.; Mateva L.; Mitova R.; Mohamed R.; Morović M.; Murphy K.; Mustapha B.; Nersesov A.; Ngige E.; Njouom R.; Njoya O.; Nonković D.; Obekpa S.; Oguche S.; Okolo E.E.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; TUNG-HUNG SU ; Sultan K.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Nde H. | Journal of Viral Hepatitis | 25 | 22 | |
43 | 2017 | Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up | Chen H.-Y.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Yang W.-T.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 12 | 9 | |
44 | 2016 | Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection | Yang W.-T.; Wu L.-W; TAI-CHUNG TSENG ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Medicine (United States) | 20 | 15 | |
45 | 2016 | Perspectives on dual hepatitis B and C infection in Taiwan | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; TAI-CHUNG TSENG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 13 | 12 | |
46 | 2016 | Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model | Li Y.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; Cheng H.-R.; YUNG-MING JENG ; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Wu H.-L. | Oncotarget | 4 | 4 | |
47 | 2016 | Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy | Hsu C.-S.; SHIH-JER HSU ; Liu W.-L.; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 12 | 10 | |
48 | 2016 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update | Sarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; DING-SHINN CHEN ; HUEY-LING CHEN ; PEI-JER CHEN ; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; CHUN-JEN LIU ; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; JIA-HORNG KAO | Hepatology International | 1819 | 1662 | |
49 | 2016 | Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients | Wu H.-L.; Hsiao T.-H.; PEI-JER CHEN ; Wong S.-H.; JIA-HORNG KAO ; DING-SHINN CHEN ; Lu J.-Y.; TZU-PIN LU ; Chen Y.; Chuang E.Y.; Tu H.-C.; CHUN-JEN LIU ; ERIC YAO-YU CHUANG | Scientific Reports | 23 | 22 | |
50 | 2016 | Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway | Liu W.-L.; HUNG-CHIH YANG ; Hsu C.-S; Wang C.-C; Wang T.-S; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 9 | 9 | |
51 | 2016 | Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Hepatology | 35 | 31 | |
52 | 2016 | Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C | Mah Y.-H.; CHEN-HUA LIU ; CHI-LING CHEN ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 6 | 7 | |
53 | 2015 | Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 8 | 8 | |
54 | 2015 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 7 | 7 | |
55 | 2015 | Systematic review: Impact of interferon-based therapy on HCV-related hepatocellular carcinoma | Hsu C.-S.; Chao Y.-C.; Lin H.H.; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 56 | 46 | |
56 | 2015 | Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection | Song L.-W.; Liu P.-G; CHUN-JEN LIU ; Zhang T.-Y; Cheng X.-D; Wu H.-L; HUNG-CHIH YANG ; Hao X.-K; Yuan Q; Zhang J; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Clinical Microbiology and Infection | 98 | 86 | |
57 | 2015 | Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; Yang W.-T; Tsai C.-S; Kuo S.F.-T; Verbree F.C; TUNG-HUNG SU ; Wang C.-C; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gut | 98 | 84 | |
58 | 2015 | Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology International | 14 | 11 | |
59 | 2015 | New insights into the evolutionary rate of hepatitis B virus at different biological scales | Lin Y.-Y.; Liu C.; Chien W.-H.; Wu L.-L.; Tao Y.; Wu D.; Lu X.; Hsieh C.-H.; PEI-JER CHEN ; HURNG-YI WANG ; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Virology | 28 | 27 | |
60 | 2015 | Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection | Hsu C.-S.; Liu W.-L.; Chao Y.-C.; Lin H.H.; TAI-CHUNG TSENG ; Wang C.-C.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 28 | 28 | |
61 | 2015 | Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping | CHEN-HUA LIU ; Liang C.-C; CHUN-JEN LIU ; Lin C.-L; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Clinical Microbiology | 58 | 55 | |
62 | 2015 | Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; Yang W.-T; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 48 | 43 | |
63 | 2015 | Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition | TUNG-HUNG SU ; Shiau C.-W; Jao P; CHEN-HUA LIU ; CHUN-JEN LIU ; Tai W.-T; YUNG-MING JENG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; HSIANG-PO HUANG ; Cheng H.-R; PEI-JER CHEN ; Chen K.-F; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 65 | 62 | |
64 | 2015 | Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study | CHEN-HUA LIU ; WANG-HUEI SHENG ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Lo Y.-C; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Liu W.-C; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 13 | 12 | |
65 | 2015 | Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial | CHEN-HUA LIU ; CHUN-JEN LIU ; Huang C.-F; JOU-WEI LIN ; Dai C.-Y; Liang C.-C; Huang J.-F; Hung P.-H; Tsai H.-B; MENG-KUN TSAI ; CHIH-YUAN LEE ; Chen S.-I; Yang S.-S; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang W.-L; Yu M.-L; JIA-HORNG KAO | Gut | 36 | 30 | |
66 | 2015 | On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy | YI-WEN HUANG ; Takahashi S.; Tsuge M.; CHI-LING CHEN ; Wang T.-C.; Abe H.; Hu J.-T.; DING-SHINN CHEN ; Yang S.-S.; Chayama K.; JIA-HORNG KAO | Antiviral Therapy | 61 | 57 | |
67 | 2015 | Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nation-wide cohort study | YI-WEN HUANG ; Wang T.-C.; Yang S.-S.; Lin S.-Y.; Fu S.-C.; Hu J.-T.; CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Alimentary Pharmacology and Therapeutics | 23 | 23 | |
68 | 2015 | Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages | CHUN-JEN LIU ; Chen T.-C.; PEI-JER CHEN ; HURNG-YI WANG ; TAI-CHUNG TSENG ; Cheng H.-R.; CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 1 | 1 | |
69 | 2015 | Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan | CHI-LING CHEN ; Yang J.-Y.; Lin S.-F.; Sun C.-A.; Bai C.-H.; You S.-L.; Chen C.-J.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 62 | 56 | |
70 | 2015 | Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy | Liang C.-C.; CHEN-HUA LIU ; Chung C.-S; Lin C.-K; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 7 | 6 | |
71 | 2014 | Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 13 | 9 | |
72 | 2014 | Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L.; Chen T.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Liver International | 13 | 11 | |
73 | 2014 | A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin | Hsu C.-S.; SHIH-JER HSU ; Lin H.H.; TAI-CHUNG TSENG ; Wang C.-C.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 8 | 7 | |
74 | 2014 | Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications | Wu H.-L.; JIA-HORNG KAO ; Chen T.-C; Wu W.-H; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; DING-SHINN CHEN ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 28 | 24 | |
75 | 2014 | Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study | Huang Y.-W.; Yang S.-S.; Fu S.-C.; Wang T.-C.; Hsu C.-K.; DING-SHINN CHEN ; Hu J.-T.; JIA-HORNG KAO | Hepatology | 95 | 87 | |
76 | 2014 | Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy | YI-WEN HUANG ; Hsu C.-K.; Lin S.-C.; SHU-CHEN WEI ; Hu J.-T.; Chang H.-Y.; Liang C.-W.; DING-SHINN CHEN ; PEI-JER CHEN ; PING-NING HSU ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 20 | 17 | |
77 | 2014 | Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin | Chen M.-Y.; CHEN-HUA LIU ; Chen T.-C.; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 8 | 7 | |
78 | 2014 | Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy | TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; YUNG-MING JENG ; Cheng H.-R; CHEN-HUA LIU ; TAI-CHUNG TSENG ; THAI-YEN LING ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology | 16 | 14 | |
79 | 2014 | The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo | Lin S.-R.; HUNG-CHIH YANG ; Kuo Y.-T; CHUN-JEN LIU ; Yang T.-Y; Sung K.-C; Lin Y.-Y; HURNG-YI WANG ; Wang C.-C; Shen Y.-C; Wu F.-Y; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Molecular Therapy - Nucleic Acids | 325 | 301 | |
80 | 2014 | Peginterferon α in the treatment of chronic hepatitis B | TAI-CHUNG TSENG ; JIA-HORNG KAO ; DING-SHINN CHEN | Expert Opinion on Biological Therapy | 19 | 17 | |
81 | 2014 | Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan | CHI-LING CHEN ; WEI-SHIUNG YANG ; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Chen C.-J. | Cancer Epidemiology Biomarkers and Prevention | 19 | 16 | |
82 | 2013 | Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO | Annals of internal medicine | 85 | 77 | |
83 | 2013 | Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C | TUNG-HUNG SU ; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; Ting T.-T.; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 53 | 52 | |
84 | 2013 | Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up | Yu M.-L.; Lee C.-M; CHI-LING CHEN ; Chuang W.-L; Lu S.-N; CHEN-HUA LIU ; Wu S.-S; Liao L.-Y; Kuo H.-T; Chao Y.-C; Tung S.-Y; Yang S.-S; JIA-HORNG KAO ; Su W.-W; Lin C.-L; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology | 65 | 59 | |
85 | 2013 | Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Yang W.-T; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 45 | 44 | |
86 | 2013 | Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients | Hsu C.-S.; SHIH-JER HSU ; Chen H.-C.; CHEN-HUA LIU ; Jeng J.; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 5 | 5 | |
87 | 2013 | Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Hsu C.-A; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 219 | 195 | |
88 | 2013 | Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: A nationwide cohort study | Huang Y.-W.; Wang T.-C.; Lin S.-C.; Chang H.-Y.; DING-SHINN CHEN ; Hu J.-T.; Yang S.-S.; JIA-HORNG KAO | Clinical Infectious Diseases | 81 | 75 | |
89 | 2013 | Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 43 | 35 | |
90 | 2013 | Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients | Yuan Q.; Song L.-W.; CHUN-JEN LIU ; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Gut | 67 | 63 | |
91 | 2013 | Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy | Huang Y.-W.; Lin S.-C.; SHU-CHEN WEI ; Hu J.-T.; Chang H.-Y.; Huang S.-H.; DING-SHINN CHEN ; PEI-JER CHEN ; PING-NING HSU ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 44 | 37 | |
92 | 2013 | IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients | Hsu C.-S.; SHIH-JER HSU ; Liu W.-L.; CHI-LING CHEN ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 10 | 8 | |
93 | 2013 | Milder clinical manifestation of scrub typhus in Kinmen, Taiwan | TUNG-HUNG SU ; CHUN-JEN LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 20 | 15 | |
94 | 2013 | Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients | Huang Y.-W.; Hu J.-T.; Hu F.-C.; Chang C.-J.; Chang H.-Y.; JIA-HORNG KAO ; Yang S.-S.; DING-SHINN CHEN | Antiviral Therapy | 8 | 8 | |
95 | 2013 | Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | PLoS ONE | 21 | 16 | |
96 | 2013 | Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion | HUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 43 | 37 | |
97 | 2013 | Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study | Dai C.-Y.; TAI-CHUNG TSENG ; Wong G.L.H.; Huang J-F.; Wong V.W.S.; CHUN-JEN LIU ; Yu M.-L.; Chuang W.-L.; JIA-HORNG KAO ; Yuen Chan H.L.; DING-SHINN CHEN | Journal of Antimicrobial Chemotherapy | 20 | 19 | |
98 | 2012 | High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 430 | 381 | |
99 | 2012 | Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 40 | 39 | |
100 | 2012 | Impact of hepatitis B virus infection on metabolic profiles and modifying factors | Hsu C.-S.; CHEN-HUA LIU ; Wang C.-C.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 60 | 54 | |
101 | 2012 | Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 129 | 115 | |
102 | 2012 | Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B | Pan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; JIA-HORNG KAO ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN | Hepatology International | 17 | 15 | |
103 | 2012 | Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma | JIA-HORNG KAO ; CHUN-JEN LIU ; Jow G.-M.; PEI-JER CHEN ; DING-SHINN CHEN ; Chen B.-F. | Liver International | 33 | 30 | |
104 | 2012 | Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 44 | 43 | |
105 | 2012 | Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin | CHEN-HUA LIU ; Liang, Cheng-Chao; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin, Chih-Lin; Yang, Sheng-Shun; TUNG-HUNG SU ; JOU-WEI LIN ; Chen, Jun-Herng; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral therapy | 21 | 22 | |
106 | 2012 | Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission | Lin C.-L.; TAI-CHUNG TSENG ; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 1 | 1 | |
107 | 2012 | Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; Wang C.-C.; TUNG-HUNG SU ; Kuo S.F.-T.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 47 | 44 | |
108 | 2011 | Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients | CHEN-HUA LIU ; Liang, Cheng-Chao; KAI-WEN HUANG ; CHUN-JEN LIU ; Chen, Shih-I; JOU-WEI LIN ; Hung, Peir-Haur; Tsai, Hung-Bin; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical journal of the American Society of Nephrology : CJASN | 71 | 69 | |
109 | 2011 | The clinical significance of occult hepatitis B transfusion in Taiwan - a look-back study | TUNG-HUNG SU ; PEI-JER CHEN ; Chen T.-C.; Cheng H.-R.; Li L.; Lin K.-S.; JIA-HORNG KAO ; DING-SHINN CHEN ; CHUN-JEN LIU | Transfusion Medicine | 30 | 26 | |
110 | 2011 | Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses | Yeh M.-L.; Hung C.-H.; Huang J.-F.; CHUN-JEN LIU ; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; DING-SHINN CHEN | PLoS ONE | 19 | 15 | |
111 | 2011 | Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan | Mah Y.-H.; Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 12 | 10 | |
112 | 2011 | Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy | Hsu C.-S.; SHIH-JER HSU ; Chen H.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; Niu W.-F.; Jeng J.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 56 | 54 | |
113 | 2011 | Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Wang C.; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 180 | 167 | |
114 | 2011 | Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C | CHUN-JEN LIU ; Cheng H.-R.; Chen C.-L.; Chen T.-C.; TAI-CHUNG TSENG ; Wang Z.-L.; PEI-JER CHEN ; CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 20 | 19 | |
115 | 2011 | Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling | Hsu C.-S.; Chen H.-C.; Jeng J.; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 0 | 0 | |
116 | 2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | TAI-CHUNG TSENG ; Yu M.-L.; CHUN-JEN LIU ; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU ; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 76 | 70 | |
117 | 2011 | HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection | SHIH-JER HSU ; Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 6 | 5 | |
118 | 2010 | Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B | TUNG-HUNG SU ; Hsu C.-S.; CHI-LING CHEN ; CHEN-HUA LIU ; Huang Y.-W.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 78 | 73 | |
119 | 2010 | Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B | Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; DING-SHINN CHEN ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 39 | 38 | |
120 | 2010 | The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; DING-SHINN CHEN ; JIA-HORNG KAO | Kidney International | 31 | 32 | |
121 | 2010 | HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses | Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN ; JIA-HORNG KAO ; Lai M.-Y.; CHEN-HUA LIU ; TUNG-HUNG SU ; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Infectious Diseases | 42 | 37 | |
122 | 2010 | Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 30 | 26 | |
123 | 2010 | Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection | Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; TAI-CHUNG TSENG ; Chen C.-H.; Su W.-C.; CHUN-JEN LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 14 | 16 | |
124 | 2010 | Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; SHIH-JER HSU ; CHI-LING CHEN ; HWANG, JUEY-JEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 30 | 30 | |
125 | 2010 | Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan | Huang Y.-W.; Liao Y.-T.; Chen W.; CHI-LING CHEN ; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; Yang S.-S.; JIA-HORNG KAO | Genes and Immunity | 45 | 38 | |
126 | 2010 | Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma. Epidemiologic and molecular biological aspects | JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Advances in Cancer Research | 72 | 68 | |
127 | 2009 | Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease | Hsu C.-S.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 0 | 0 | |
128 | 2009 | Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B | CHUN-JEN LIU ; YUNG-MING JENG ; CHI-LING CHEN ; Cheng H.-R.; PEI-JER CHEN ; Chen T.-C.; CHEN-HUA LIU ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 26 | 21 | |
129 | 2009 | Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses | CHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN ; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO ; CHEN-HUA LIU ; Su W.; Lin C.; YUNG-MING JENG ; PEI-JER CHEN ; DING-SHINN CHEN | Gastroenterology | 182 | 157 | |
130 | 2009 | Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; Wang C.-C.; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 37 | 34 | |
131 | 2009 | Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Wang C.-C.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 16 | 12 | |
132 | 2009 | Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy | TAI-CHUNG TSENG ; CHUN-JEN LIU ; SONG-CHOU HSIEH ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Digestive and Liver Disease | 3 | 3 | |
133 | 2009 | Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; Tsai H.-B.; Hung P.-H.; SHIH-JER HSU ; Chen S.-L.; JOU-WEI LIN ; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gut | 26 | 23 | |
134 | 2009 | Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C | Hsieh T.-H.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; Hsieh H.-L.; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 30 | 24 | |
135 | 2009 | Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 33 | 30 | |
136 | 2009 | Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus | Huang Y.-W.; CHUNG-YI HU ; CHI-LING CHEN ; Liao Y.-T.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; Yang S.-S.; Hu J.-T.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Medical Virology | 7 | 6 | |
137 | 2009 | High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; CHEN-HUA LIU ; CHI-LING CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology International | 32 | 29 | |
138 | 2008 | Critical analysis of the immune tolerance phase of chronic HBV infection: Natural history and diagnosis | JIA-HORNG KAO ; DING-SHINN CHEN | Current Hepatitis Reports | 4 | 0 | |
139 | 2008 | Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis | Wang C.-C.; Hsu C.-S.; CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 86 | 75 | |
140 | 2008 | Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial | CHEN-HUA LIU ; CHUN-JEN LIU ; Lin C.-L.; Liang C.-C.; SHIH-JER HSU ; Yang S.-S.; Hsu C.-S.; TAI-CHUNG TSENG ; Wang C.-C.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 183 | 170 | |
141 | 2008 | A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Wang C.-C.; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 19 | 17 | |
142 | 2008 | Universal Hepatitis B Vaccination: Killing 2 Birds with 1 Stone | JIA-HORNG KAO ; DING-SHINN CHEN | American Journal of Medicine | 12 | 12 | |
143 | 2008 | Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis | CHEN-HUA LIU ; SHIH-JER HSU ; Liang C.-C.; FENG-CHIAO TSAI ; JOU-WEI LIN ; CHUN-JEN LIU ; PEI-MING YANG ; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; JIA-HORNG KAO ; DING-SHINN CHEN | Radiology | 27 | 24 | |
144 | 2008 | Disease progression in a patient with nonalcoholic steatohepatitis | PING-HUEI TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO ; CHIA-TUNG SHUN ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 6 | |
145 | 2008 | Metabolic profiles in patients with chronic hepatitis C: A case-control study | Hsu C.-S.; CHUN-JEN LIU ; CHEN-HUA LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 27 | 28 | |
146 | 2008 | Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infection | TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 0 | 0 | |
147 | 2008 | Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study | CHEN-HUA LIU ; Liang C.-C.; JOU-WEI LIN ; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN | Gut | 67 | 61 | |
148 | 2008 | Hepatitis B viral genotype in Taiwanese patients with acute hepatitis B | YI-WEN HUANG ; Lin C.-L.; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Hepato-Gastroenterology | 7 | 6 | |
149 | 2008 | High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C | Hsu C.-S.; CHUN-JEN LIU ; CHEN-HUA LIU ; Wang C.-C.; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 95 | 91 | |
150 | 2007 | Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index | CHEN-HUA LIU ; SHIH-JER HSU ; JOU-WEI LIN ; JUEY-JEN HWANG ; CHUN-JEN LIU ; PEI-MING YANG ; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 27 | 22 | |
151 | 2007 | Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies | YEN-HSUAN NI ; LI-MIN HUANG ; MEI-HWEI CHANG ; CHUNG-JEN YEN ; CHUN-YI LU ; You S.; JIA-HORNG KAO ; Lin Y.; HUEY-LING CHEN ; HONG-YUAN HSU ; DING-SHINN CHEN | Gastroenterology | 274 | 252 | |
152 | 2007 | Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma | Lin C.-L.; CHEN-HUA LIU ; Chen W.; Huang W.-L.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 78 | 74 | |
153 | 2007 | Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients | Wang C.-C.; CHUN-JEN LIU ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 7 | 7 | |
154 | 2007 | Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan | Hsu C.-S.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Intervirology | 17 | 16 | |
155 | 2007 | Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma | Lin C.-L.; Chen J.-D.; CHUN-JEN LIU ; PO-HUANG LEE ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Viral Hepatitis | 23 | 21 | |
156 | 2007 | Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels | Lin C.-L.; Liao L.-Y.; CHUN-JEN LIU ; MING-WHEI YU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 97 | 92 | |
157 | 2007 | Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma | FENG-CHIAO TSAI ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Viral Hepatitis | 17 | 17 | |
158 | 2007 | Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan | TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; Lin C.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 15 | 15 | |
159 | 2007 | High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users | Lin C.-L.; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Medical Virology | 24 | 22 | |
160 | 2007 | APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers [5] | TUNG-HUNG SU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 0 | 0 | |
161 | 2007 | Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6] | CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | New England Journal of Medicine | 1 | 1 | |
162 | 2006 | HBV genotypes: Epidemiology and implications regarding natural history | JIA-HORNG KAO ; DING-SHINN CHEN | Current Hepatitis Reports | 30 | 0 | |
163 | 2006 | Mixed hepatitis B virus genotype infections: The more, the worse? [3] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 8 | 5 | |
164 | 2006 | Selective transmission of hepatitis C virus quasi species through a needlestick accident in acute resolving hepatitis | CHEN-HUA LIU ; Chen, Bing-Fang; SHU-CHING CHEN ; Lai, Ming-Yang; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical Infectious Diseases | 11 | 12 | |
165 | 2006 | Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized study | CHUN-JEN LIU ; Lai M.-Y.; Chao Y.-C.; Liao L.-Y.; Yang S.-S.; Hsiao T.-J.; Hsieh T.-Y.; Lin C.-L.; Hu J.-T.; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 41 | 35 | |
166 | 2006 | Local ablation vs. resection for the treatment of hepatocellular carcinoma [1] | JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 5 | 4 | |
167 | 2006 | Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; Lin F.-Y.; Wang T.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 37 | 35 | |
168 | 2006 | Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C | Chen B.-F.; CHUN-JEN LIU ; Jow G.-M.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of General Virology | 32 | 28 | |
169 | 2006 | Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: A case-control study | Lin C.-J.; Chen B.-F.; PEI-JER CHEN ; Lai M.-Y.; Huang W.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Infectious Diseases | 117 | 110 | |
170 | 2006 | Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases | CHEN-HUA LIU ; JOU-WEI LIN ; FENG-CHIAO TSAI ; PEI-MING YANG ; Lai M.-Y.; Chen J.-H.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 54 | 52 | |
171 | 2006 | Clinical significance of occult hepatitis B virus infection cannot be overlooked [11] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical Infectious Diseases | 1 | 1 | |
172 | 2006 | Kinetics of Hepatitis B Virus Reactivation After Chemotherapy: More Questions Than Answers | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Gastroenterology | 7 | 7 | |
173 | 2006 | The Woodchuck Model for the Study of HBV-associated Hepatopathy-husbandry, Management and Laboratory Techniques | Lin, H.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN ; Lee, P.-J.; Wu, H.-L. | Taiwan Veterinary Journal | |||
174 | 2006 | Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: Correlation with viral characteristics | HO-HSIUNG LIN ; Wu W.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 56 | 50 | |
175 | 2006 | Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B | Huang Y.-W.; Lin C.-L.; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 15 | 14 | |
176 | 2006 | Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan | CHUN-JEN LIU ; SHYH-CHYI LO ; JIA-HORNG KAO ; Tseng P.-T.; Lai M.-Y.; YEN-HSUAN NI ; Shiou-Hwei Yeh ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 98 | 88 | |
177 | 2006 | High Prevalence and Mapping of Pre-S Deletion in Hepatitis B Virus Carriers With Progressive Liver Diseases | Chen B.; CHUN-JEN LIU ; Jow G.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Gastroenterology | 247 | 232 | |
178 | 2006 | Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Chen T.-C.; Lin F.-Y.; Lai M.-Y.; DING-SHINN CHEN | Journal of Viral Hepatitis | 14 | 12 | |
179 | 2006 | Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers | CHUN-JEN LIU ; Chen B.-F.; PEI-JER CHEN ; Lai M.-Y.; Huang W.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Infectious Diseases | 161 | 142 | |
180 | 2005 | Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men | MING-WHEI YU ; Shiou-Hwei Yeh ; PEI-JER CHEN ; Liaw Y.-F.; Lin C.-L.; CHUN-JEN LIU ; WEI-LIANG SHIH ; JIA-HORNG KAO ; DING-SHINN CHEN ; Chen C.-J. | Journal of the National Cancer Institute | 496 | 426 | |
181 | 2005 | Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus | Lin C.-L.; JIA-HORNG KAO ; Chen B.-F.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Clinical Infectious Diseases | 41 | 36 | |
182 | 2005 | Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: A prospective study | GUAN-TARN HUANG ; PO-HUANG LEE ; Tsang Y.-M.; Lai M.-Y.; PEI-MING YANG ; REY-HENG HU ; PEI-JER CHEN ; JIA-HORNG KAO ; JIN-CHUAN SHEU ; Lee, Cha-Ze ; DING-SHINN CHEN | Annals of Surgery | 177 | 163 | |
183 | 2005 | Hepatitis B vaccination: To boost or not to boost? | JIA-HORNG KAO ; DING-SHINN CHEN | Lancet | 28 | 29 | |
184 | 2005 | Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C | CHUN-JEN LIU ; PEI-JER CHEN ; YUNG-MING JENG ; Huang W.-L.; WEI-SHIUNG YANG ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Hepatology | 67 | 59 | |
185 | 2005 | Successful treatment with peginterferon and ribavirin in a patient with acute hepatitis C evolving into chronicity | Hsieh T.-H.; JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 0 | 0 | |
186 | 2005 | Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia | JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 100 | 88 | |
187 | 2005 | Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan | Mah Y.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Liver International | 24 | 17 | |
188 | 2005 | Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B | Lin C.-L.; Liao L.-Y.; Wang C.-S.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 72 | 64 | |
189 | 2005 | Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C | CHUN-JEN LIU ; YUNG-MING JENG ; PEI-JER CHEN ; Lai M.-Y; HUNG-CHIH YANG ; Huang W.-L; JIA-HORNG KAO ; DING-SHINN CHEN | Antiviral Therapy | 34 | 32 | |
190 | 2005 | Therapeutic implications of hepatitis B virus genotypes | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 108 | 82 | |
191 | 2005 | HBV genotypes and outcome of HBV infection [1] (multiple letters) | JIA-HORNG KAO ; DING-SHINN CHEN ; Lok A.S.F. | Hepatology | 7 | 6 | |
192 | 2005 | Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2005 update | Liaw Y.-F.; Leung N.; Guan R.; Lau G.K.K.; Merican I.; McCaughan G.; Gane E.; JIA-HORNG KAO ; Omata M.; Chutaputti B.A.; DING-SHINN CHEN ; Chien R.N.; Cooksley G.; Han K.H.; Ichida T.; Lai M.Y.; Lesmana L.; Piratvisuth T.; Sarin S.K.; Sollano J.; Suh D.J.; Yao G.B.; Yeh C.T.; Yokosuka O. | Liver International | 334 | 271 | |
193 | 2004 | Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma | YEN-HSUAN NI ; MEI-HWEI CHANG ; Wang K.-J.; HONG-YUAN HSU ; HUEY-LING CHEN ; JIA-HORNG KAO ; Shiou-Hwei Yeh ; YUNG-MING JENG ; KEH-SUNG TSAI ; DING-SHINN CHEN | Gastroenterology | 172 | 145 | |
194 | 2004 | Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Medical Virology | 24 | 21 | |
195 | 2004 | End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B | CHUN-JEN LIU ; Huang W.-L.; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | World Journal of Gastroenterology | 14 | 12 | |
196 | 2004 | Genotypic Dominance and Novel Recombinations in HBV Genotype B and C Co-Infected Intravenous Drug Users | Chen B.-F.; JIA-HORNG KAO ; CHUN-JEN LIU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Medical Virology | 44 | 38 | |
197 | 2004 | Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy | Lin C.-L.; Liao L.-Y.; Wang C.-S.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 16 | 23 | |
198 | 2004 | High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users | Chen B.-F.; PEI-JER CHEN ; Jow G.-M.; Sablon E.; CHUN-JEN LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Medical Virology | 42 | 36 | |
199 | 2004 | Lack of interferon sensitivity-determining region in the genome of hepatitis B virus genotype Ba | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; Chen T.-C.; HURNG-YI WANG ; Huang W.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Antiviral Therapy | 9 | 8 | |
200 | 2004 | Hepatitis B Virus Genotypes and Core Promoter Variant [10] (multiple letters) | JIA-HORNG KAO ; DING-SHINN CHEN ; Lok A.S.F. | Gastroenterology | 0 | 1 | |
201 | 2004 | Hepatitis B Virus Genotypes and Spontaneous Hepatitis B e Antigen Seroconversion in Taiwanese Hepatitis B Carriers | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 150 | 132 | |
202 | 2004 | Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation | CHUN-JEN LIU ; JIA-HORNG KAO ; HURNG-YI WANG ; Lai M.-Y.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | 17 | 17 | |
203 | 2004 | Precore/Core Promoter Mutations and Genotypes of Hepatitis B Virus in Chronic Hepatitis B Patients with Fulminant or Subfulminant Hepatitis | CHUN-JEN LIU ; JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Medical Virology | 39 | 37 | |
204 | 2004 | Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis | Shiou-Hwei Yeh ; Tsai C.-Y.; JIA-HORNG KAO ; CHUN-JEN LIU ; Kuo T.-J.; Lin M.-W.; Huang W.-L.; Lu S.-F.; Jih J.; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Hepatology | 193 | 182 | |
205 | 2004 | Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma | Chen J.-D.; CHUN-JEN LIU ; PO-HUANG LEE ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical Gastroenterology and Hepatology | 45 | 44 | |
206 | 2003 | Clinical Relevance of Hepatitis B Virus Genotypes Ba and Bj in Taiwan [6] (multiple letters) | JIA-HORNG KAO ; DING-SHINN CHEN ; Sugauchi F.; Miyakawa Y.; Mizokami M. | Gastroenterology | 18 | 14 | |
207 | 2003 | A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; Chang C.-F.; Wu H.-L.; Shau W.-Y.; DING-SHINN CHEN | Gastroenterology | 58 | 54 | |
208 | 2003 | Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: A prospective study | CHUN-JEN LIU ; PEI-JER CHEN ; Shau W.-Y.; JIA-HORNG KAO ; Lai M.-Y.; DING-SHINN CHEN | Liver International | 24 | 22 | |
209 | 2003 | Molecular Assays for Hepatitis B Virus Infection [1] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 5 | 5 | |
210 | 2003 | SEN virus infection in patients with chronic hepatitis C: Preferential coinfection with hepatitis C genotype 2a and no effect on response to therapy with interferon plus ribavirin | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Infectious Diseases | 22 | 20 | |
211 | 2003 | Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan | HO-HSIUNG LIN ; JIA-HORNG KAO ; TING-CHEN CHANG ; HONG-YUAN HSU ; DING-SHINN CHEN | Journal of Medical Virology | 41 | 35 | |
212 | 2003 | Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin | Yang S.-S.; Lai M.-Y.; DING-SHINN CHEN ; Chen G.-H.; JIA-HORNG KAO | Liver International | 22 | 20 | |
213 | 2003 | Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Gastroenterology | 491 | 437 | |
214 | 2002 | Molecular epidemiology of hepatitis B viral serotypes and genotypes in Taiwan | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.Y.; DING-SHINN CHEN | Journal of Biomedical Science | 40 | 37 | |
215 | 2002 | Hepatitis B viral genotypes and lamivudine resistance [1] | JIA-HORNG KAO ; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Hepatology | 101 | 84 | |
216 | 2002 | Recent updates in hepatitis vaccination and the prevention of hepatocellular carcinoma | JIA-HORNG KAO ; DING-SHINN CHEN | International Journal of Cancer | 13 | 10 | |
217 | 2002 | Hepatitis D virus genotypes in intravenous drug users in Taiwan: Decreasing prevalence and lack of correlation with hepatitis B virus genotypes | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 41 | 17 | |
218 | 2002 | Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study | King J.K.; Shiou-Hwei Yeh ; Lin M.-W.; CHUN-JEN LIU ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Hepatology | 63 | 54 | |
219 | 2002 | Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 176 | 156 | |
220 | 2002 | Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: Correlation with viral serotypes and clinical stages of liver disease | CHUN-JEN LIU ; JIA-HORNG KAO ; Shau W.-Y.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 39 | 35 | |
221 | 2002 | Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 142 | 138 | |
222 | 2002 | Global control of hepatitis B virus infection | JIA-HORNG KAO ; DING-SHINN CHEN | Lancet Infectious Diseases | 714 | 631 | |
223 | 2002 | Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Infectious Diseases | 56 | 47 | |
224 | 2002 | Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 41 | 34 | |
225 | 2002 | Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B | Lin C.-L.; Liao L.-Y.; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology | 37 | 37 | |
226 | 2002 | Early acquisition of TT virus in infants: Possible minor role of maternal transmission | HO-HSIUNG LIN ; JIA-HORNG KAO ; PING-ING LEE ; DING-SHINN CHEN | Journal of Medical Virology | 25 | 27 | |
227 | 2002 | Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 84 | 79 | |
228 | 2002 | Recent research progress in hepatocellular carcinoma | JIA-HORNG KAO ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 20 | 21 | |
229 | 2001 | Mother-to-child HCV transmission [1] (multiple letters) | Semprini A.E.; Savasi V.; Hollander L.; Tanzi E.; Fiore S.; Newell M.-L.; Pembrey L.; Zanetti A.; Coll O.; Numazaki K.; Fujikawa T.; Chiba S.; Hari P.; Prasad C.G.K.; Lankipalli R.; HO-HSIUNG LIN ; JIA-HORNG KAO ; DING-SHINN CHEN ; Gibb D.M.; Dunn D.T.; Goodall R.L. | Lancet | 7 | 3 | |
230 | 2001 | Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan | JIA-HORNG KAO ; Hsu H.-M.; Shau W.-Y.; MEI-HWEI CHANG ; DING-SHINN CHEN | Journal of Pediatrics | 97 | 79 | |
231 | 2001 | Probable reinfection with hepatitis C virus in a chronic hepatitis C patient with a sustained response to combination therapy | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 9 | 9 | |
232 | 2001 | Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Hepatology | 73 | 68 | |
233 | 2001 | Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 46 | 46 | |
234 | 2001 | Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience | CHUN-JEN LIU ; Lai M.-Y.; PO-HUANG LEE ; NAI-KUAN CHOU ; Chu S.-H.; PEI-JER CHEN ; JIA-HORNG KAO ; Jen Y.-M.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 36 | 32 | |
235 | 2001 | Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother | Chen J.-D.; Chung J.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 13 | 12 | |
236 | 2001 | Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; Cheng Y.-M.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 0 | 2 | |
237 | 2001 | Hepatitis B virus genotypes and hepatocellular carcinoma in Japan [4] | Fujie H.; Moriya K.; Shintani Y.; Yotsuyanagi H.; Iino S.; Kimura S.; Koike K.; JIA-HORNG KAO ; DING-SHINN CHEN | Gastroenterology | 99 | 86 | |
238 | 2000 | TT virus infection in patients with chronic hepatitis B or C: Influence on clinical, histological and virological features | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 36 | ||
239 | 2000 | Interspousal transmission of TT virus: Low efficiency and lack of apparent risk factors | CHUN-JEN LIU ; JIA-HORNG KAO ; Chen W.; Tsai R.-J.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 2 | 2 | |
240 | 2000 | Transmission of hepatitis C virus in Asia: Past and present perspectives | JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 75 | 67 | |
241 | 2000 | Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: Emphasis on its relevance to hepatitis | JIN-TOWN WANG ; Lee, Cha-Ze ; JIA-HORNG KAO ; JIN-CHUAN SHEU ; Wang T.H.; DING-SHINN CHEN | Transfusion | 22 | 22 | |
242 | 2000 | Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Gastroenterology | 879 | 773 | |
243 | 2000 | Low incidence of hepatitis C virus transmission between spouses: A prospective study | JIA-HORNG KAO ; CHUN-JEN LIU ; PEI-JER CHEN ; Chen W.; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 52 | 37 | |
244 | 2000 | Hepatitis B genotypes and the response to interferon therapy | JIA-HORNG KAO ; Wu N.-H.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Hepatology | 453 | 386 | |
245 | 2000 | Efficacy of consensus interferon in the treatment of chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 12 | 7 | |
246 | 1999 | Comparison of two methods for quantification of hepatitis B viral DNA | JIA-HORNG KAO ; Wood M.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 13 | 12 | |
247 | 1999 | Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Archives of Virology | 14 | 13 | |
248 | 1999 | GB virus C infection in hemodialysis patients: Molecular evidence for nosocomial transmission | JIA-HORNG KAO ; Huang C.-H.; Chen W.; TUN-JUN TSAI ; Lee S.-H.; KUAN-YU HUNG ; DING-SHINN CHEN | Journal of Infectious Diseases | 18 | 13 | |
249 | 1999 | Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials | Schalm S.W.; Weiland O.; Hansen B.E.; Milella M.; Lai M.Y.; Hollander A.; Michielsen P.P.; Bellobuono A.; Chemello L.; Pastore G.; DING-SHINN CHEN ; Brouwer J.T.; Braconnier J.H.; Fryden A.; Norkrans G.; Reichard O.; Adler M.; Chamuleau R.A.F.M.; Delwaide J.; Elewaut A.; Fevery J.; Hautekeete M.L.; Nevens F.; Den Ouden-Muller J.W.; Wismans P.J.; Casalino C.; Maselli R.; Pietromatera G.; Chan K.W.; JIA-HORNG KAO ; Ideo G.; Alberti A.; Cavalletto L.; Boot J.; Van Vliet C. | Gastroenterology | 161 | 132 | |
250 | 1999 | Prevalence and implication of TT virus infection: Minimal role in patients with non-A-E hepatitis in Taiwan | JIA-HORNG KAO ; Chen W.; Hsiang S.-C.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 48 | ||
251 | 1999 | Molecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: Implications for occupational health practice | JIA-HORNG KAO ; Heptonstall J.; DING-SHINN CHEN | Occupational and Environmental Medicine | 11 | 9 | |
252 | 1999 | GB virus-C/hepatitis G virus infection in Taiwan: A virus that fails to cause a disease? | JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Biomedical Science | 15 | 0 | |
253 | 1999 | Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan | CHUN-JEN LIU ; JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; Chu J.-S.; Chen W.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 15 | 11 | |
254 | 1998 | Brief communication: Efficacy of ribavirin plus interferon α on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon α alone | JIA-HORNG KAO ; Lai M.-Y.; Chen W.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 10 | 10 | |
255 | 1998 | GB virus C/hepatitis G virus infection in patients on continuous ambulatory peritoneal dialysis | Huang C.-H.; JIA-HORNG KAO ; Kuo Y.-M.; TUN-JUN TSAI ; KUAN-YU HUNG ; DING-SHINN CHEN | Nephrology Dialysis Transplantation | 7 | 8 | |
256 | 1998 | Mother-to-infant transmission of GB virus C/hepatitis G virus: The role of high-titered maternal viremia and mode of delivery | HO-HSIUNG LIN ; JIA-HORNG KAO ; Yeh K.-Y.; DING-PING LIU ; MEI-HWEI CHANG ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Infectious Diseases | 48 | 42 | |
257 | 1998 | Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections | JIA-HORNG KAO ; Chen R.-J.; Lai M.-Y.; Chen W.; DING-SHINN CHEN | Archives of Virology | 16 | 13 | |
258 | 1998 | Hepatitis C virus infection in Taiwan | JIA-HORNG KAO ; DING-SHINN CHEN | Chinese Journal of Public Health | 0 | ||
259 | 1997 | GB virus-C/hepatitis G virus infection in prostitutes: Possible role of sexual transmission | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.Y.; Lin R.Y.; DING-SHINN CHEN | Journal of Medical Virology | 35 | ||
260 | 1997 | Blood-bank screening for hepatitis G [14] | JIA-HORNG KAO ; PEI-JER CHEN ; JIN-TOWN WANG ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 7 | 5 | |
261 | 1997 | GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Chen W.; DING-PING LIU ; JANN-TAY WANG ; Shen M.- C.; DING-SHINN CHEN | Gastroenterology | 82 | 73 | |
262 | 1997 | Immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 5 | 2 | |
263 | 1997 | Interspousal transmission of GB virus-C/Hepatitis G virus: A comparison with hepatitis C virus | JIA-HORNG KAO ; CHUN-JEN LIU ; PEI-JER CHEN ; Chen W.; Hsiang S.-C.; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 34 | ||
264 | 1997 | Benign recurrent intrahepatic cholestasis | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; TSUI-LIEN MAO ; Wang T.-H.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 1 | 0 | |
265 | 1997 | Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: No correlation with viral genotypes 1b, 2a, and 2b | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | Journal of Medical Virology | 45 | ||
266 | 1997 | Amplification of GB virus-C/hepatitis G virus RNA with primers from different regions of the viral genome | JIA-HORNG KAO ; PEI-JER CHEN ; Chen W.; Hsiang S.C.; Lai M.Y.; DING-SHINN CHEN | Journal of Medical Virology | 50 | ||
267 | 1996 | Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay: A clinicopathologic study and demonstration of the usefulness of a third-generation assay | JIA-HORNG KAO ; Lai M.-Y.; Hwang Y.-T.; PEI-MING YANG ; PEI-JER CHEN ; JIN-CHUAN SHEU ; Wang T.-H.; Hsu H.-C.; DING-SHINN CHEN | Digestive Diseases and Sciences | 48 | 44 | |
268 | 1996 | Least microtransfusion from mother to fetus in elective cesarean delivery | HO-HSIUNG LIN ; JIA-HORNG KAO ; HONG-YUAN HSU ; Mizokami M.; Hirano K.; DING-SHINN CHEN | Obstetrics and Gynecology | 62 | 47 | |
269 | 1996 | Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C | Lai M.-Y.; JIA-HORNG KAO ; PEI-MING YANG ; JIN-TOWN WANG ; PEI-JER CHEN ; KIN-WEI CHAN ; Chu J.- S.; DING-SHINN CHEN | Gastroenterology | 282 | 255 | |
270 | 1996 | Serum hepatitis C virus titers in the progression of type C chronic liver disease with special emphasis on patients with type 1b infection | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; Hwang L.-H.; DING-SHINN CHEN | Journal of Clinical Gastroenterology | 7 | 7 | |
271 | 1996 | Superinfection by homotypic virus in hepatitis C virus carriers: Studies on patients with post-transfusion hepatitis | JIA-HORNG KAO ; PEI-JER CHEN ; JANN-TAY WANG ; PEI-MING YANG ; Lai M.Y.; Wang T.H.; DING-SHINN CHEN | Journal of Medical Virology | 34 | ||
272 | 1996 | GBV-C in the aetiology of fulminant hepatitis [6] | JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Mishiro S.; Yoshiba M.; Okamoto H. | Lancet | 83 | 87 | |
273 | 1996 | Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: Correlation with genotypes | JIA-HORNG KAO ; HO-HSIUNG LIN ; PEI-JER CHEN ; Lai M.-Y.; Wang T.-H.; Mizokami M.; DING-SHINN CHEN | Journal of Gastroenterology | 16 | 16 | |
274 | 1996 | Hepatitis G virus in intravenous immunoglobulin [1] | PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN ; Healey C.J.; Chapel H.; Simmonds P.; Chapman R.W.G. | Gastroenterology | 2 | 2 | |
275 | 1996 | Serotypes, genotypes and levels of hepatitis C viremia in pregnant women in Taiwan | HO-HSIUNG LIN ; JIA-HORNG KAO ; Mizokami M.; Huang S.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 5 | 3 | |
276 | 1996 | Transmission of hepatitis C virus between spouses: The important role of exposure duration | JIA-HORNG KAO ; Hwang Y.-T.; PEI-JER CHEN ; PEI-MING YANG ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | American Journal of Gastroenterology | 83 | 66 | |
277 | 1996 | Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; Hwang L.-H.; Chen W.; DING-SHINN CHEN | American Journal of Gastroenterology | 31 | 28 | |
278 | 1996 | Identification of humoral antigenic determinants in the hepatitis C virus NS3 protein | Hwang L.-H.; PEI-MING YANG ; Lai M.-Y.; BOR-LUEN CHIANG ; JIA-HORNG KAO ; Wang, Jin-Town ; Lee S.-Y.; Chian H.-M.; Chi W.-K.; Chu Y.-D.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Infectious Diseases | 13 | 12 | |
279 | 1996 | GBV-C/HGV infection and aplastic anaemia [7] | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 9 | 8 | |
280 | 1996 | Rapid hepatic failure associated with a contracted liver mimicking cirrhosis in a case of nasopharyngeal carcinoma with liver metastasis | Hwang Y.-T.; PEI-JER CHEN ; JIA-HORNG KAO ; Wang T.-D.; Wang H.-H.; Chu J.-S.; Su I.-J.; DING-SHINN CHEN | Liver | 9 | 9 | |
281 | 1996 | Phylogenetic analysis of GB virus C: Comparison of isolates from Africa, North America, and Taiwan | JIA-HORNG KAO ; PEI-JER CHEN ; Hsiang S.-C.; Chen W.; DING-SHINN CHEN | Journal of Infectious Diseases | 51 | 52 | |
282 | 1996 | Absence of extensive genetic heterogeneity of hepatitis C virus in antibody-negative chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; PEI-MING YANG ; Lai M.Y.; Wang T.H.; DING-SHINN CHEN | Journal of Medical Virology | 11 | ||
283 | 1996 | Mechanism of vertical transmission of hepatitis G [6] | HO-HSIUNG LIN ; IA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Lancet | 40 | 27 | |
284 | 1995 | Letter | HO-HSIUNG LIN ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | The Journal of Pediatrics | |||
285 | 1995 | Reply To the Editor | Lin H.-H.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | The Journal of Pediatrics | 0 | 0 | |
286 | 1995 | Genotypes of hepatitis C virus in taiwan and the progression of liver disease | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; PEI-MING YANG ; JIN-CHUAN SHEU ; Wang T.-H.; DING-SHINN CHEN | Journal of Clinical Gastroenterology | 62 | 56 | |
287 | 1995 | Prevalence, Genotypes and Antibody Titer of Hepatitis C Virus in Pregnant Women in Taiwan | HO-HSIUNG LIN ; JIA-HORNG KAO ; Huang S. C.; Lee T. Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Obstetrics and Gynaecology | 7 | 0 | |
288 | 1995 | Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C | PEI-MING YANG ; Hwang L.-H.; Lai M.-Y.; Huang W.-L.; Chu Y.-D.; Chi W.-K.; BOR-LUEN CHIANG ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Clinical and Experimental Immunology | 8 | 7 | |
289 | 1995 | Early interferon therapy and abortion of posttransfusion hepatitis C viral infection | Yang S.-S.; Wu C.-H.; Huang, C.-S.; Ho, M.-S.; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Clinical Gastroenterology | |||
290 | 1995 | Intrafamilial transmission of hepatitis C virus in hemodialysis patients | Hou C.-H.; Chen W.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN ; Yang Y.; Chen J.-J.; Lee S.-H.; Wu D.-J.; Yang S.-C. | Journal of Medical Virology | 42 | 33 | |
291 | 1994 | Mixed infections of hepatitis c virus as a factor in acute exacerbations of chronic type c hepatitis | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; PEI-MING YANG ; JIN-CHUAN SHEU ; Wang T.-H.; DING-SHINN CHEN | Journal of Infectious Diseases | 75 | 73 | |
292 | 1994 | Possible role of high-titer maternal viremia in perinatal transmission of hepatitis c virus | HO-HSIUNG LIN ; JIA-HORNG KAO ; HONG-YUAN HSU ; YEN-HSUAN NI ; Shiou-Hwei Yeh ; Hwang L.-H.; MEI-HWEI CHANG ; Hwang S.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Infectious Diseases | 180 | 140 | |
293 | 1994 | A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients | JIA-HORNG KAO ; Tsai S.-L.; PEI-JER CHEN ; PEI-MING YANG ; JIN-CHUAN SHEU ; Lai M.-Y.; Hsu H.-C.; Sung J.-L.; Wang T.-H.; DING-SHINN CHEN | Journal of Hepatology | 38 | 36 | |
294 | 1994 | Detection of divergent hepatitis C virus envelope sequences | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; PEI-MING YANG ; JIN-CHUAN SHEU ; Wang T.-H.; DING-SHINN CHEN | Journal of Biomedical Science | 4 | 0 | |
295 | 1994 | Hepatitis C Virus Infection in Pregnant Women: Detection by Different Anti‐HCV Immunoassays and Serum HCV‐RNA | HO-HSIUNG LIN ; HONG-YUAN HSU ; Lee T.-Y.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Asia-Oceania Journal of Obstetrics and Gynaecology | 2 | 0 | |
296 | 1993 | Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Gastroenterology | 92 | 101 | |
297 | 1993 | Comparison of Three Different Immunoassays and PCR for the Detection of Hepatitis C Virus Infection in Pregnant Women in Taiwan | HO-HSIUNG LIN ; JIA-HORNG KAO ; Leu J. H.; Young Y. C.; Lee T. Y.; PEI-JER CHEN ; DING-SHINN CHEN | Vox Sanguinis | 11 | 10 | |
298 | 1992 | Intrafamilial Transmission of Hepatitis C Virus: The Important Role of Infections between Spouses | JIA-HORNG KAO ; PEI-JER CHEN ; PEI-MING YANG ; Lai M.-Y.; JIN-CHUAN SHEU ; Wang T.-H.; DING-SHINN CHEN | Journal of Infectious Diseases | 148 | 139 | |
299 | 1992 | Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: Putative serological marker for acute viral infection | PEI-JER CHEN ; JIN-TOWN WANG ; Hwang L.-H.; Yang Y.-H.; Hsieh C.-L.; JIA-HORNG KAO ; JIN-CHUAN SHEU ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 61 | 59 | |
300 | 1991 | Therapeutic effect of ursodeoxycholic acid on early-stage primary biliary cirrhosis | JIA-HORNG KAO ; Lai M.Y.; Lin J.W.; PEI-MING YANG ; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Sung J.L.; Wang T.H. | Journal of the Formosan Medical Association | 4 | 0 |